Frequent SPAC investors Francisco Partners announced this morning that they have launched a cash tender offer to purchase 7,500,000 Pathfinder (NASDAQ:PFDR) Class A shares for $10 per share. The offer will expire on January 4, 2023, at 11:59 p.m. EST.
Francisco Partners is also to acquire a one-fifth warrant per share and holders and the move is a part of a commitment letter it signed on October 3 and equity grant agreement announced November 14. Under this agreement, Francisco Partners is to receive an additional 1,000,000 shares and Movella is to issue $25 million in senior secured notes to it.
These notes hold a 9.25% interest rate, which is to increase by 0.5% each year on the anniversary of the November 14 signing. This financing may form an important backstop as Pathfinder may need to extend its February 19, 2023 completion deadline.
Pathfinder initially announced its $537 million combination with Movella on October 4 and terminated an earlier combination agreement with ServiceMax in December 2021. San Jose, California-based Movella provides motion-capture hardware and software for the entertainment, health and manufacturing industries.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...